Marco Montagner

Dr. Marco Montagner

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in Cell
Verified
Journal Article
Closed access
MCMichelangelo Cordenonsi
Michelangelo Cordenonsi
FZFrancesca Zanconato
Francesca Zanconato
LALuca Azzolin
Luca Azzolin
MFMattia Forcato
Mattia Forcato
ARAntonio Rosato
Antonio Rosato
SPStefano Piccolo
Stefano Piccolo

1 April 2009 in Cell
Verified
Journal Article
Closed access
MAMaddalena Adorno
Maddalena Adorno
MCMichelangelo Cordenonsi
Michelangelo Cordenonsi
MMMarco Montagner
Marco Montagner
SDSirio Dupont
Sirio Dupont
CWChristine Wong
Christine Wong
SPStefano Piccolo
Stefano Piccolo

1 January 2009 in Cell
Verified
Journal Article
Closed access
SDSirio Dupont
Sirio Dupont
AMAnant Mamidi
Anant Mamidi
MCMichelangelo Cordenonsi
Michelangelo Cordenonsi
MMMarco Montagner
Marco Montagner
LZLuca Zacchigna
Luca Zacchigna
SPStefano Piccolo
Stefano Piccolo

14 February 2022 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
Patrizia RomaniPatrizia Romani
Patrizia Romani
NNNunzia Nirchio
Nunzia Nirchio
MAMattia Arboit
Mattia Arboit
VBVito Barbieri
Vito Barbieri
ATAnna Tosi
Anna Tosi
SDSirio Dupont
Sirio Dupont

8 July 2012 in Nature
Verified
Journal Article
Closed access
PDF file
MMMarco Montagner
Marco Montagner
EEElena Enzo
Elena Enzo
MFMattia Forcato
Mattia Forcato
FZFrancesca Zanconato
Francesca Zanconato
APAnna Parenti
Anna Parenti
SPStefano Piccolo
Stefano Piccolo

9 February 2007 in Science
Verified
Journal Article
Closed access
PDF file
MCMichelangelo Cordenonsi
Michelangelo Cordenonsi
MMMarco Montagner
Marco Montagner
MAMaddalena Adorno
Maddalena Adorno
LZLuca Zacchigna
Luca Zacchigna
GMGraziano Martello
Graziano Martello
SPStefano Piccolo
Stefano Piccolo
During development and tissue homeostasis, cells must integrate different signals. We investigated how cell behavior is controlled by the combined activity of transforming growth factor–β (TGF-β) and receptor tyrosine kinase (RTK) signaling, whose integration mechanism is unknown. We find that RTK/Ras/MAPK (mitogen-activated protein kinase) activity induces p53 N-terminal phosphorylation, enabling the interaction of p53 with the TGF-β–activated Smads. This mechanism confines mesoderm specification in Xenopus embryos and promotes TGF-β cytostasis in human cells. These data indicate a mechanism to allow extracellular cues to specify the TGF-β gene-expression program.